Following Jon Jones’ massive return win over former Daniel Cormier, things are now looking far from good for the 205-pound reigning kingpin.light heavyweight champion
A very sad story opened up for Jones on Tuesday after a TMZ post surfaced about him failing another drug test for UFC 214. According to the news outlet, Jones tested positive for steroid turinabol, a banned substance which carries a two-year suspension from USADA for first-time offenders and longer for multiple-time offenders.
USADA did confirm that Jones failed an in-competition drug test conducted on July 28th, but has not officially revealed the substance until Jones announces it himself.
Given that Mr. Jones’ representative has publicly commented on the case, USADA can confirm that he has been notified of a potential anti-doping policy violation stemming from an in-competition sample he provided after his weigh-in on July 28, 2017. Because this is an ongoing case, at this time we are not going to provide any further details.
Jones previously failed a drug test for UFC 200 in July 2016. He was ultimately suspended and served a one-year ban by USADA for testing positive for two banned substances, clomiphene and letrozol. At the moment, there’s a good chance Jones will be stripped and Cormier will remain the champion.
Stay tuned tofor much more daily news in MMA.
Official Statement From The UFC
The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Jon Jones of a potential Anti-Doping Policy violation stemming from an in-competition sample collected following his weigh-in on July 28, 2017.
USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case involving Jones, as it relates to the UFC Anti-Doping Policy and future UFC participation. Under the UFC Anti-Doping Policy, there is a full and fair legal process that is afforded to all athletes before any sanctions are imposed. The California State Athletic Commission (CSAC) also retains jurisdiction over this matter as the sample collection was performed the day before Jones’ bout at UFC 214 in Anaheim, CA, and USADA will work to ensure that the CSAC has the necessary information to determine its proper judgment of Jones’ potential anti-doping violation.
Additional information will be provided at the appropriate time as the process moves forward.